AbbVie Inc. (ABBV) vs Palantir Technologies Inc. (PLTR)

AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.

Palantir Technologies is an artificial intelligence, data analytics, and automated decision-making company that helps organizations improve efficiency through data-driven operations. It serves commercial customers through its Foundry platform and government clients through Gotham. Palantir works exclusively with organizations in Western-allied nations and maintains the right to decline engagements it views as contrary to Western values. Founded in 2003, the company became publicly traded in 2020.